Testing effectiveness (Phase 2)Study completedNCT01614795
What this trial is testing
Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
Who this might be right for
Childhood Alveolar Soft Part SarcomaChildhood AngiosarcomaChildhood Epithelioid Sarcoma+12 more
National Cancer Institute (NCI) 46